Innovaderma Plc

Innovaderma (IDP)

Company name:Innovaderma Plc
EPIC:IDPTrading Currency:GBX
Market Sector:SQS3ISIN:GB00BT9PTW34
Market Segment:SSQ3Share Type:DE
WWW Address: EUR0.10
 Price Price Change [%] Bid Offer Open High Low Volume
 29.00 0.0 [0.00] - - - - - -
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 7.94 27.37 0.01 -10.49 - - - 39.00 - 25.00

Innovaderma Key Figures

(at previous day's close)
Market Cap.7.94m
Shares In Issue27.37m
Prev. Close29.00
PE Ratio- 
Dividend Yield-%
EPS - basic-10.49p
Dividend PS-p
Dividend Cover- 
Cash Flow PS-6.76p
Return On Equity (ROE)-67.06%
Operating Margin-18.44%
PEG Factor- 
EPS Growth Rate-550.00%
Dividends PS Growth Rate-%
Net Debt0.87m
Gross Gearing51.08%
Quick Assets3.06m
Net Working Capital1.80m
Intangibles / Fixed Assets74.17%
Turnover PS26.97p
Pre-Tax Profit PS-4.97p
Retained Profit PS-5.95p
Cash PS6.17p
Net Cash PS-3.19p
Net Tangible Asset Value PS *7.11p
Net Asset Value PS8.97p
Spread- (-%) 

Innovaderma Balance Sheet


Share Price Performance

Sorry No Data Available

Share Price Chart (5 years)

Innovaderma Historic Returns

Sorry No Data Available

Innovaderma Key Management Ratios

Innovaderma Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio- 
PE Ratio- 
Tobin's Q Ratio 0.75 
Tobin's Q Ratio (excl. intangibles)1.25 
Dividend Yield-%
Market-to-Book Ratio3.27 
Price-to-Pre-Tax Profit PS-5.83 
Price-to-Retained Profit PS-4.87 
Price-to-Cash Flow PS-4.29 
Price-to-Sales PS1.08 
Price-to-Net Tangible Asset Value PS4.02 
Price-to-Cash PS4.70 
Net Working Capital PS6.59 
Price Pct to Working Capital PS4.40%
Earnings Yield-%
Average PE41.42 
Years in average2 
PE to PE average-%

Innovaderma Financial Ratios

(Leverage Ratios)
Debt Ratio-%
Debt-to-Equity Ratio- 
Debt-to-Equity Ratio (excl. Intgbl)- 
Debt-to-Equity Market Value- 
Net Gearing17.41%
Net Gearing (excl. Intangibles)19.27%
Gross Gearing51.08%
Gross Gearing (excl. Intangibles)56.53%
Gearing Under 1 Year51.08%
Gearing Under 1 Year (excl. Intgbl)56.53%
(Liquidity Ratios)
Net Working Capital to Total Assets35.93%
Current Ratio1.70 
Quick Ratio (Acid Test)1.19 
Liquidity Ratio0.66 
Cash & Equiv/Current Assets38.70%
(Solvency Ratios)
Enterprise Value6.27m
CFO/Attributable Profit- 
Total Debt/Equity Market Value0.32 
Total Debt/Sales0.35 
Total Debt/Pre-Tax Profit-1.88 
Total Debt2.56m
Total Debt/Net Current Assets1.42%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth-%
5 yr Compound Earnings Growth-%
10 yr Compound Earnings Growth-%
Earn drops > 5% in 10yrs3 
Beta (60-Mnth)Beta (36-Mnth)

Innovaderma Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)-55.43%
Return On Assets (ROA)-15.39%
Net Profit Margin-22.07%
Assets Turnover0.70 
Return On Equity (ROE)-67.06%
Return On Investment (ROI)-23.73%
Dividend Payout Ratio-%
Plowback Ratio100.00%
Growth from Plowback Ratio-%
Net Income Of Revenues-22.07%
(Asset Utilisation Multiples)
Shareholders Equity Turnover1.08 
Fixed Assets Turnover1.66 
Current Assets Turnover1.20 
Net Working Capital Turnover 
Inventory Turnover3.00 
(Other Operating Ratios)
Total Assets-to-Sales1.43 
Debt Collection Period93.74Days

Innovaderma Dividends

Sorry No Data Available

Innovaderma Fundamentals

 30 Jun 2018 (USD)30 Jun 2019 (USD)30 Jun 2020 (USD)30 Jun 2021 (USD)
pre tax profit0.676.25%1.4110.98%-0.38-2.84%-1.88-18.44%m
attributable profit0.292.72%0.836.43%-0.34-2.53%-2.25-22.07%m
retained profit0.292.72%0.836.43%-0.34-2.53%-2.25-22.07%m
eps - basic- 7.00 -2.00 -13.00 
eps - diluted- 7.00 -2.00 -13.00 
dividends per share- - - - 

Innovaderma Balance Sheet

 30 Jun 2018 (USD)30 Jun 2019 (USD)30 Jun 2020 (USD)30 Jun 2021 (USD)
 30 Jun 2018 (USD)30 Jun 2019 (USD)30 Jun 2020 (USD)30 Jun 2021 (USD)
fixed assets fixed assets0.050.35%0.050.36%0.151.05%0.233.36%m
intangibles intangibles5.6944.46%6.5844.15%7.8154.89%0.679.63%m
fixed investments fixed investments0.030.24%0.020.12%0.020.11%--%m
current assets - other current assets - other--%--%--%--%m
stocks stocks2.8722.44%2.3615.87%3.1221.90%1.8126.04%m
debtors debtors2.2617.63%3.8425.80%1.9013.33%1.9027.30%m
cash & securities cash & securities1.9114.88%2.0413.71%1.248.72%2.3433.67%m
creditors - short creditors - short2.9523.02%4.1627.92%3.8927.35%3.5551.08%m
creditors - long creditors - long0.020.13%-0.00-0.00%0.000.01%--%m
creditors - other creditors - other--%--%--%--%m
subordinated loans subordinated loans--%--%--%--%m
insurance funds insurance funds--%--%--%--%m
ord cap, reserves ord cap, reserves9.8476.86%10.7472.09%10.3472.64%3.3648.40%m
prefs, minorities prefs, minorities--%--%--%0.040.52%m
NAV Basic- - - - 
NAV Diluted- - - - 

Innovaderma Cash Flow Statement

30 Jun 2018 (USD)30 Jun 2019 (USD)30 Jun 2020 (USD)30 Jun 2021 (USD)
Operating CF0.101.180.60-2.56m
Pre-Financing CF-1.960.25-0.76-2.95m
Retained CF1.560.37-0.761.07m

Innovaderma Brokers

Broker infomation is not available for this class of stock.
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now
NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20230202 02:43:46